Stephen R. Hann - Publications

Affiliations: 
Vanderbilt University, Nashville, TN 
Area:
Cell Biology, Genetics, Microbiology Biology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Zhang Q, West-Osterfield K, Spears E, Li Z, Panaccione A, Hann SR. MB0 and MBI Are Independent and Distinct Transactivation Domains in MYC that Are Essential for Transformation. Genes. 8. PMID 28481271 DOI: 10.3390/genes8050134  0.48
2015 Broadus MR, Yew PR, Hann SR, Lee E. Small-molecule high-throughput screening utilizing Xenopus egg extract. Methods in Molecular Biology (Clifton, N.J.). 1263: 63-73. PMID 25618336 DOI: 10.1007/978-1-4939-2269-7_5  1
2014 Sekhar KR, Benamar M, Venkateswaran A, Sasi S, Penthala NR, Crooks PA, Hann SR, Geng L, Balusu R, Abbas T, Freeman ML. Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization. International Journal of Radiation Oncology, Biology, Physics. 89: 1106-14. PMID 25035215 DOI: 10.1016/j.ijrobp.2014.04.012  1
2013 Zhang Q, Spears E, Boone DN, Li Z, Gregory MA, Hann SR. Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity. Proceedings of the National Academy of Sciences of the United States of America. 110: 978-83. PMID 23277542 DOI: 10.1073/pnas.1208334110  1
2012 Nifoussi SK, Vrana JA, Domina AM, De Biasio A, Gui J, Gregory MA, Hann SR, Craig RW. Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer. Plos One. 7: e47060. PMID 23056582 DOI: 10.1371/journal.pone.0047060  1
2011 Boone DN, Hann SR. The Myc-ARF-Egr1 pathway: unleashing the apoptotic power of c-Myc. Cell Cycle (Georgetown, Tex.). 10: 2043-4. PMID 21709445 DOI: 10.4161/cc.10.13.15711  1
2011 Boone DN, Qi Y, Li Z, Hann SR. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proceedings of the National Academy of Sciences of the United States of America. 108: 632-7. PMID 21187408 DOI: 10.1073/pnas.1008848108  1
2009 Li Z, Hann SR. The Myc-nucleophosmin-ARF network: a complex web unveiled. Cell Cycle (Georgetown, Tex.). 8: 2703-7. PMID 19652540  0.48
2008 Li Z, Boone D, Hann SR. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation. Proceedings of the National Academy of Sciences of the United States of America. 105: 18794-9. PMID 19033198 DOI: 10.1073/pnas.0806879105  0.48
2008 Chandramohan V, Mineva ND, Burke B, Jeay S, Wu M, Shen J, Yang W, Hann SR, Sonenshein GE. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor. Journal of Cellular Biochemistry. 104: 2091-106. PMID 18393360 DOI: 10.1002/jcb.21765  1
2006 Vaknin UA, Hann SR. The alpha1 subunit of GABAA receptor is repressed by c-myc and is pro-apoptotic. Journal of Cellular Biochemistry. 97: 1094-103. PMID 16294320 DOI: 10.1002/jcb.20708  1
2005 Hsia N, Brousal JP, Hann SR, Cornwall GA. Recapitulation of germ cell- and pituitary-specific expression with 1.6 kb of the cystatin-related epididymal spermatogenic (Cres) gene promoter in transgenic mice. Journal of Andrology. 26: 249-57. PMID 15713831  0.32
2005 Gregory MA, Qi Y, Hann SR. The ARF tumor suppressor: keeping Myc on a leash. Cell Cycle (Georgetown, Tex.). 4: 249-52. PMID 15655352  1
2004 Qi Y, Gregory MA, Li Z, Brousal JP, West K, Hann SR. p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature. 431: 712-7. PMID 15361884 DOI: 10.1038/nature02958  1
2004 Domina AM, Vrana JA, Gregory MA, Hann SR, Craig RW. MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Oncogene. 23: 5301-15. PMID 15241487 DOI: 10.1038/sj.onc.1207692  1
2003 Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. The Journal of Biological Chemistry. 278: 51606-12. PMID 14563837 DOI: 10.1074/jbc.M310722200  1
2000 Gregory MA, Xiao Q, Cornwall GA, Lutterbach B, Hann SR. B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation. Oncogene. 19: 4886-95. PMID 11039906 DOI: 10.1038/sj.onc.1203851  1
2000 Claassen GF, Hann SR. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Proceedings of the National Academy of Sciences of the United States of America. 97: 9498-503. PMID 10920185 DOI: 10.1073/pnas.150006697  1
2000 Niklinski J, Claassen G, Meyers C, Gregory MA, Allegra CJ, Kaye FJ, Hann SR, Zajac-Kaye M. Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma. Molecular and Cellular Biology. 20: 5276-84. PMID 10866684 DOI: 10.1128/MCB.20.14.5276-5284.2000  1
2000 Chang DW, Claassen GF, Hann SR, Cole MD. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Molecular and Cellular Biology. 20: 4309-19. PMID 10825194 DOI: 10.1128/MCB.20.12.4309-4319.2000  1
2000 Gregory MA, Hann SR. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Molecular and Cellular Biology. 20: 2423-35. PMID 10713166 DOI: 10.1128/MCB.20.7.2423-2435.2000  1
1999 Claassen GF, Hann SR. Myc-mediated transformation: the repression connection. Oncogene. 18: 2925-33. PMID 10378689 DOI: 10.1038/sj.onc.1202747  1
1995 Arsura M, Deshpande A, Hann SR, Sonenshein GE. Variant max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation Molecular and Cellular Biology. 15: 6702-6709. PMID 8524235 DOI: 10.1128/MCB.15.12.6702  1
1995 Hoang AT, Lutterbach B, Lewis BC, Yano T, Chou TY, Barrett JF, Raffeld M, Hann SR, Dang CV. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-myc transactivation domain Molecular and Cellular Biology. 15: 4031-4042. PMID 7623799  1
1994 Hann SR, Dixit M, Sears RC, Sealy L. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes & Development. 8: 2441-52. PMID 7958908 DOI: 10.1101/gad.8.20.2441  1
1990 Levine RA, Seshadri T, Hann SR, Campisi J. Posttranscriptional changes in growth factor-inducible gene regulation caused by antiproliferative interferons Cell Regulation. 1: 215-226. PMID 2100198 DOI: 10.1091/mbc.1.2.215  1
1988 Hann SR, King MW, Bentley DL, Anderson CW, Eisenman RN. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas Cell. 52: 185-195. PMID 3277717 DOI: 10.1016/0092-8674(88)90507-7  1
Show low-probability matches.